TAO Synergies (TAOX) Market Capitalization (2020 - 2026)
TAO Synergies' (TAOX) quarterly Market Capitalization came in at $27.9 million in Q2 2026, up 126.87% on a YoY basis from $12.3 million in Q2 2025, and down 34.44% quarter-over-quarter from $42.5 million in Q1 2026.
Analysis
TAO Synergies (TAOX) Market Capitalization (2020 - 2026) Analysis & Trends
TAO Synergies (TAOX) has reported Market Capitalization for 7 consecutive years, with $27.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Market Capitalization rose 126.87% year-over-year to $27.9 million; the trailing twelve-month figure through Jun 2026 stood at $27.9 million (up 126.87% YoY), and the FY2025 full-year result was $12.1 million, up 157.88% from the prior year.
- Market Capitalization fell to $27.9 million in Q2 2026 per TAOX's latest filing, from $42.5 million in the prior quarter.
- Across five years, Market Capitalization topped out at $1.3 billion in Q1 2022 and bottomed at $3.4 million in Q1 2025.
- Historically, Market Capitalization has averaged $233.7 million across 5 years, with a median of $35.2 million in 2026.
- The sharpest annual moves came in 2024 and 2026: Market Capitalization plunged 96.99% in 2024, then jumped 1164.07% in 2026.
- Over 5 years, Market Capitalization stood at $210.7 million in 2022, then sank by 62.4% to $79.2 million in 2023, then sank by 94.06% to $4.7 million in 2024, then surged by 157.88% to $12.1 million in 2025, then surged by 129.52% to $27.9 million in 2026.
- According to Business Quant data, Market Capitalization over the past three periods registered $27.9 million, $42.5 million, and $12.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 210.98 Bn | 196.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.24 Bn | 178.06 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.38 Bn | 124.53 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.97 Bn | 74.97 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn |
| 6 | Moderna | 54.80 Bn | 49.67 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.09 Bn | 30.78 Bn | 992.69 Mn |
| 8 | Biogen | 31.34 Bn | 30.05 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.11 Bn | 30.11 Bn | 1.16 Mn |
| 10 | TAO Synergies | 30.79 Mn | 30.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.87 Mn |
| Mar 31, 2026 | 42.52 Mn |
| Dec 31, 2025 | 12.14 Mn |
| Sep 30, 2025 | 16.70 Mn |
| Jun 30, 2025 | 12.29 Mn |
| Mar 31, 2025 | 3.36 Mn |
| Dec 31, 2024 | 4.71 Mn |
| Sep 30, 2024 | 4.09 Mn |
| Jun 30, 2024 | 5.14 Mn |
| Mar 31, 2024 | 5.10 Mn |
| Dec 31, 2023 | 79.23 Mn |
| Sep 30, 2023 | 117.73 Mn |
| Jun 30, 2023 | 170.87 Mn |
| Mar 31, 2023 | 147.20 Mn |
| Dec 31, 2022 | 210.74 Mn |
| Sep 30, 2022 | 1.15 Bn |
| Jun 30, 2022 | 883.64 Mn |
| Mar 31, 2022 | 1.32 Bn |
| Dec 31, 2021 | 1.07 Bn |
| Sep 30, 2021 | 1.53 Bn |